These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34194433)

  • 1. PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.
    Shen C; Liu C; Zhang Z; Ping Y; Shao J; Tian Y; Yu W; Qin G; Liu S; Wang L; Zhang Y
    Front Immunol; 2021; 12():680055. PubMed ID: 34194433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 3. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.
    Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC
    Front Immunol; 2023; 14():1244437. PubMed ID: 37781372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune crosstalk in asthmatic airways: Innate lymphoid cells coordinate polarization of lung macrophages.
    Kim J; Chang Y; Bae B; Sohn KH; Cho SH; Chung DH; Kang HR; Kim HY
    J Allergy Clin Immunol; 2019 May; 143(5):1769-1782.e11. PubMed ID: 30414858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXR
    You W; Li L; Sun D; Liu X; Xia Z; Xue S; Chen B; Qin H; Ai J; Jiang H
    Cancer Immunol Res; 2019 Jun; 7(6):990-1000. PubMed ID: 30975694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRP-alpha-IL-6 axis induces immunosuppressive macrophages in non-small-cell lung cancer.
    Wang B; Pan L; Chen M; Ma Y; Gao J; Tang D; Jiang Z
    Biochem Biophys Res Commun; 2023 Nov; 682():386-396. PubMed ID: 37844448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression.
    Yin C; Pa Y; Li G; Chen Q; Wang X; He X; Zhou H
    Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):417-423. PubMed ID: 38678437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased IL-10+CD206+CD14+M2-like macrophages in alveolar lavage fluid of patients with small cell lung cancer.
    Hu X; Gu Y; Zhao S; Hua S; Jiang Y
    Cancer Immunol Immunother; 2020 Dec; 69(12):2547-2560. PubMed ID: 32583155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity.
    Yue J; Guo H; Xu P; Ma J; Shi W; Wu Y
    Cancer Immunol Immunother; 2024 Mar; 73(4):65. PubMed ID: 38430390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
    Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
    Front Immunol; 2019; 10():2829. PubMed ID: 31921114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.
    Lo Russo G; Moro M; Sommariva M; Cancila V; Boeri M; Centonze G; Ferro S; Ganzinelli M; Gasparini P; Huber V; Milione M; Porcu L; Proto C; Pruneri G; Signorelli D; Sangaletti S; Sfondrini L; Storti C; Tassi E; Bardelli A; Marsoni S; Torri V; Tripodo C; Colombo MP; Anichini A; Rivoltini L; Balsari A; Sozzi G; Garassino MC
    Clin Cancer Res; 2019 Feb; 25(3):989-999. PubMed ID: 30206165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer.
    Wang L; Yang H; Dorn P; Berezowska S; Blank F; Wotzkow C; Marti TM; Peng RW; Harrer N; Sommergruber W; Kocher GJ; Schmid RA; Hall SRR
    EBioMedicine; 2021 Nov; 73():103664. PubMed ID: 34740105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis.
    Narayanapillai SC; Han YH; Song JM; Kebede ME; Upadhyaya P; Kassie F
    Carcinogenesis; 2020 Nov; 41(11):1518-1528. PubMed ID: 32602900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
    Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
    Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.
    Chen X; Zhou J; Wang Y; Wang X; Chen K; Chen Q; Huang D; Jiang R
    Oncogene; 2024 Aug; 43(33):2517-2530. PubMed ID: 39004633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues.
    Fan TW; Higashi RM; Song H; Daneshmandi S; Mahan AL; Purdom MS; Bocklage TJ; Pittman TA; He D; Wang C; Lane AN
    Elife; 2021 Aug; 10():. PubMed ID: 34406120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer.
    Ritzmann F; Jungnickel C; Vella G; Kamyschnikow A; Herr C; Li D; Menger MM; Angenendt A; Hoth M; Lis A; Bals R; Beisswenger C
    Sci Rep; 2019 Jul; 9(1):10353. PubMed ID: 31316109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 Is Involved in the Dysregulation of Type 2 Innate Lymphoid Cells in a Murine Model of Obesity.
    Oldenhove G; Boucquey E; Taquin A; Acolty V; Bonetti L; Ryffel B; Le Bert M; Englebert K; Boon L; Moser M
    Cell Rep; 2018 Nov; 25(8):2053-2060.e4. PubMed ID: 30463004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.